Sir Richard Branson will launch his most controversial business to date as he moves into stem-cell storage and the biotech sector, The Times has learnt.
The Virgin-branded company will be launched next Thursday and is expected to offer parents the chance to put the umbilical blood of their newborn children into cold storage. Scientists believe that future advances in medical technology will use stem cells to cure diseases such as Alzheimer’s and cancer.
The move into stem-cell storage is part of a strategy that Sir Richard is developing to invest in technologies of the future. He has already launched Virgin Galactic, which will take tourists into space, and is investing all the profits of Virgin Atlantic, his airline, in the development of environmentally friendly biofuels...
The rest of this Times (U.K.) article is here.